FDA Regulations.
2025 · 2nd Quarter (Apr 1 - June 30)
OSRX PHARMACEUTICALS
Filed by TODD STRATEGY GROUP.
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Termination
- Posted
- Oct 12, 2025
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- TODD STRATEGY GROUP
- Client
- OSRX PHARMACEUTICALS
- Filing UUID
- d56e3775-8cea-4a88-b3ed-9f3b182ca83b
- Termination date
- Jun 30, 2025
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.